![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.457, 2004-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Enoxaparin sodium cost effective for VTE prophylaxis
Inpharma, Vol. 1, Iss. 1546, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Enoxaparin sodium cost effective for VTE prophylaxis
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 507, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Fondaparinux a step up for VTE prophylaxis
Inpharma, Vol. 1, Iss. 1417, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Fondaparinux a step up for VTE prophylaxis
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 442, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Extended-duration enoxaparin for VTE prophylaxis promising
Inpharma, Vol. 1, Iss. 1599, 2007-01 ,pp. :